Bioterrorism and Bioterrorism Preparedness: Historical Perspective and Overview

Infectious Disease Clinics of North America

Volumn 20, Issue 2, 2006, Pages 179-211

  Khardori, Nancy ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; ANTHRAX VACCINE; ANTIINFECTIVE AGENT; BACTERIAL VACCINE; HEPATITIS A VACCINE; MONOCLONAL ANTIBODY; OX 19; PROTOZOAL VACCINE; RICKETTSIA VACCINE; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VACCINE;

ACTIVE IMMUNIZATION; ANTHRAX; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BIOSAFETY; CHOLERA; DRUG HYPERSENSITIVITY; EBOLA VIRUS; EDUCATION PROGRAM; EMERGENCY; EPIDEMIC; GASTROENTERITIS; HEALTH CARE COST; HOSPITAL LABORATORY; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; LAW; NONHUMAN; PLAGUE; PROTECTIVE EQUIPMENT; PUBLIC HEALTH SERVICE; RECOGNITION; REVIEW; SALMONELLA; SALMONELLOSIS; SERRATIA MARCESCENS; SHIGELLA; SHIGELLA DYSENTERIAE; SHIGELLOSIS; SKIN DECONTAMINATION; SMALLPOX; SPECIES CULTIVATION; URINARY TRACT INFECTION; VIBRIO CHOLERAE; VIRUS HEMORRHAGIC FEVER; WAR; YERSINIA PESTIS; YERSINIOSIS;

BIOTERRORISM; DISASTER PLANNING; DISEASE OUTBREAKS; HISTORY, 18TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HUMANS; PUBLIC HEALTH; UNITED STATES;

EID: 33744509613     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2006.03.007     Document Type: Review

References (73)

1. Centers for Disease Control and Prevention. US Department of Health and Human Services, the public health response to biological and chemical terrorism, interim planning guidance for state public health officials. 2001. Available at: http://www.be.cdc.gov/Documents/Planning/PlanningGuidance.
2. Drexler M. Secret agents: the menace of emerging infections (2002), Joseph Henry Press, Washington, DC
3. Gostin L.O., Sapsin J.W., Teret S.P., et al. The model state emergency health powers act: planning for and response to bioterrorism and naturally occurring infectious diseases. JAMA 288 (2002) 622-628
4. Eitzen E.M., and Takafuji E.T. Historical overview of biological warfare. In: Sidell F.R., Takafuju E.F., and Franz D.R. (Eds). Medical aspects of chemical and biological warfare: textbook of military medicine part I: warfare, weaponry and the casualty (1997), Borden Institute, Washington, DC 415-423
5. Christopher G.W., Cieslak T.J., Pavlin J.A., et al. Biological warfare: a historical perspective. JAMA 278 (1997) 412-417
6. Poupard J., and Miller L. History of biological warfare: catapults to capsomers. Ann N Y Acad Sci 666 (1992) 9-20
7. Stubbs M. Has the West an Achilles heel: possibilities of biological weapons. NATO's Fifteen Nations 7 (1962) 94-99
8. Derbes V.J. De Mussis and the great plague of 1348: a forgotten episode of bacteriological warfare. JAMA 96 (1966) 179-182
9. Hopkins D.R. Princes and peasants: smallpox in history (1983), University of Chicago Press, Chicago
10. Hugh-Jones M. Wickham Steed and German biological warfare research. Intell Natl Secur 7 (1992) 379-402
11. Geissler E. Biological and toxin weapons: research, development and use from the Middle Ages to 1945. SIPRI Chemical and Biological Warfare Studies. No. 16 (1986), Oxford University Press, New York
12. Harris S. Japanese biological warfare research on humans: a case study of microbiology and ethics. Ann N Y Acad Sci 666 (1992) 21-52
13. Manchee R.J., and Steward R. The decontamination of Gruinard Island. Chem Br 24 (1988) 690-691
14. Nitscherlich A., and Mielke F. Medizin ohne menschlichkeit: Dokuments des Nurnberger Arzteprozesses (1983), Frankfurt am Main: Fischer Taxchenbuchverla
15. Davis C.J. Nuclear blindness: an overview of the biological weapons program of the former Soviet Union and Iraq. Emerg Infect Dis 5 (1999) 509-512
16. Henderson D.A. Bioterrorism as a public health threat. Emerg Infect Dis 4 (1998) 488-492
17. Henderson D.A. Strengthening global preparedness for defense against infectious diseases threats (2001), Hearing on the threat of bioterrorism and the spread of infectious disease, 1st Session, 107th Congress
18. Zalinskas R.A. Iraq's biological weapons? The past or future?. JAMA 278 (1997) 418-424
19. Rorberts B. New challenges and new policy priorities for the 1990's. Biologic weapons; weapons of the future (1993), Center for Strategic and International Studies, Washington, DC
20. Bartlett J.G. Update in infectious diseases. Ann Intern Med 131 (1999) 273-280
21. Carus W.S. Bioterrorism and biocrimes: the illicit use of biological agents in the 20th century (1999), Center for Counterproliferation Research, National Defense University, Washington, DC
22. Henderson D.A. The looming threat of bioterrorism. Science 283 (1999) 1279-1282
23. Kortepeter M.G., and Parker G.W. Potential biological weapons threats. Emerg Infect Dis 5 (1999) 523-527
24. Relman D.A., and Olson J.E. Bioterrorism preparedness: what practitioners need to know. Infect Med 18 (2001) 497-514
25. Tucker J.B. Historical trends related to bioterrorism: an empirical analysis. Emerg Infect Dis 5 (1999) 498-504
26. Khardori N., and Kanchanapoom T. Overview of biological terrorism: potential agents and preparedness. Clin Microb News 27 (2005) 1-8
27. Stewart C. Toxins and biowarfare in biological warfare: preparing for the unthinkable emergency. Topics in Emergency Medicine, Vol II (2001), American Health Consults, Atlanta
28. Hawley R.J., and Eitzen Jr. E.M. Biological weapons-a primer for microbiologists. Annu Rev Microbiol 55 (2001) 235-253
29. Richards C.F., Burstein J.L., Waeckerle J., et al. Emergency physicians and biological terrorism. Ann Emerg Med 34 (1999) 182-190
30. Kaufmann A.F., Meltzer M.I., and Schnid G.P. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?. Emerg Infect Dis 3 (1997) 83-94
31. Obstacles to biodefense. [editorial]. Nature 419 (2002) 1
32. Heymann DL. Strengthening global preparedness for defense against infectious disease threats. Committee on Foreign Relations, United States Senate. Hearing on the threat of bioterrorism and the spread of infectious diseases. 1st Session, 107th Congress; 2001.
33. NACo. County public health preparedness. 2002. Available at: www.naco.org/pubs/surveys/pubhealth/index.cfm.
34. DiGiovanni C., Reynolds B., Harwell R., et al. Community reaction to bioterrorism: prospective study of simulated outbreak. Emerg Infect Dis 9 (2003) 708-712
35. Boulton M.D., Abellera J., Lemmings J., et al. Terrorism and emergency preparedness in state and territorial public health departments-United States. MMWR 54 (2005) 459-460
36. Lessons learned from a full-scale bioterrorism exercise. Emerg Infect Dis 6 (2000) 652-654
37. Inglesby T.V., Grossman R., and O'Toole R. A plague on your city: observations from TOPOFF. Clin Infect Dis 32 (2001) 436-444
38. O'Toole T., Mair M., and Inglesby T.V. Shining light on "Dark Winter.". Clin Infect Dis 34 (2002) 972-983
39. Atlas R.M. Bioterrorism: from threat to reality. Annu Rev Microbiol 56 (2002) 167-185
40. Frase-Blunt M. "Operation TOPOFF 2" bioterrorism exercise offers educational lessons. AAMC Reporter; 2003. Available at: www.aamc/org/august03/bioterrorism.html.
41. Nelson R. Simulation shows lack of readiness for bioterrorism attack. Lancet Infect Dis 5 (2003) 139
42. Dennis C. The bugs of war. Nature 411 (2001) 232-235
43. General Accounting Office. Combating terrorism: need to eliminate duplicate federal weapons of mass destruction training. [GAO/NSAID-00-64]. 2000.
44. General Accounting Office. Combating terrorism: observations on the Nunn-Lugar-Domenici Domestic Preparedness Program. [GAO/T-NSAID-99-16]. 1998.
45. Khardori N. Bioterrorism preparedness: historical prespective and overview. In: Khardori N. (Ed). Bioterrorism preparedness: medicine-public health-policy (2006), Wiley-VCH, Weinheim
46. Siegrist D.W. The threat of biological attack: why concern now. Emerg Infect Dis 5 (1999) 505-508
47. Tonat K. Office of Emergency Preparedness, US Department of Health and Human Services panel discussion at conference "Integrating Medical and Emergency Response." Washington, DC; 1999.
48. Khan A.S., Morse S., and Lillibridge S. Public-health preparedness for biological terrorism in the USA. Lancet 356 (2000) 1179-1182
49. Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR Morb Mortal Wkly Rep 49(RR-4) (2000) 1-14
50. Meyer R.F. Bioterrorism preparedness for the public health and medical communities. Mayo Clin Proc 77 (2002) 619-621
51. Khardori N. Preparedness for bioterrorism. In: Meyers R.A. (Ed). Encyclopedia of molecular cell biology and molecular medicine (2004), Wiley-VCH, Weinheim 507-528
52. LRN Network. 2004. Available at: http://www.cdc.gov/od/ohs/pdffiles/Module%202%20-%Biosafety.pdf and http://www.cdc.gov/od/ohs/biosfty/bmbl4bmbl4toc.htm.
53. English JF, Cundiff MY, Malone JD, et al. Bioterrorism readiness plan: a template for healthcare facilities. APIC Bioterrorism Task Force and the CDC Hospital Infections Program Bioterrorism Working Group; 1999. p. 1-33.
54. USAMRIID's medical management of biological casualties handbook. 5th edition (2004), US Army Medical Research Institute of Infectious Diseases, Fort Detrick (MD)
55. Inglesby T.V., O'Toole T., Henderson D.A., et al. Anthrax as a biological weapon-updated recommendations for management. In: Henderson D.A., Inglesby T.V., and O'Toole T. (Eds). Bioterrorism: guidelines for medical and public health management (2002), American Medical Association, Chicago 66-98
56. Inglesby T.V., Dennis D.T., Henderson D.A., et al. Plague as a biological weapon. In: Henderson D.A., Inglesby T.V., and O'Toole T. (Eds). Bioterrorism: guidelines for medical and public health management (2002), American Medical Association, Chicago 121-140
57. Arnon S.S., Schecter R., Inglesby T.V., et al. Botulinum toxin as a biological weapon. In: Henderson D.A., Inglesby T.V., and O'Toole T. (Eds). Bioterrorism: guidelines for medical and public health management (2002), American Medical Association, Chicago 141-166
58. Dennis D.T., Inglesby T.V., Henderson D.A., et al. Tularemia as a biological weapon. In: Henderson D.A., Inglesby T.V., and O'Toole T. (Eds). Bioterrorism: guidelines for medical and public health management (2002), American Medical Association, Chicago 167-190
59. Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis 8 (2002) 833-884
60. McKinney W.P., Bia F.J., Stewart C.S., et al. Bioterrorism: an update for clinicians, pharmacists, and emergency management planners. Emergency medicine consensus reports (2001), American Health Consultants, Atlanta
61. Zoon K.C. Vaccines, pharmaceutical products and bioterrorism: challenges for the US Food and Drug Administration. Emerg Infect Dis 5 (1999) 534
62. Annas G.J. Bioterrorism, public health, and civil liberties. N Engl J Med 346 (2002) 1337-1342
63. Department of Health and Human Services. Federal Register, 42 CFR 72; 2005.
64. Centers for Disease Control and Prevention Select Agent Program. FAQ for new regulation (2003), CDC Office of the Director. Available at: www.cdc.gov/od/sap/addres/htm
65. Horton H.H., Misrahi J.J., Matthew G.W., et al. Critical biological agents: disease reporting as a tool for determining bioterrorism preparedness. J Law Med Ethics 30 (2002) 262-266
66. Chang M., Glynn K., and Groseclose S.L. Endemic, notifiable bioterrorism-related diseases, United States, 1992-1999. Emerg Infect Dis 9 (2003) 556-563
67. Hoffman R.E. Preparing for a bioterrorist attack: legal and administrative strategies. Emerg Infect Dis 9 (2003) 241-245
68. World Health Organization. Public health response to biological and chemical weapons (2004), WHO guidance. http://www.who.int/csr/delibepidemics/biochemguide/en/index.html Available at: http://www.who.int/csr/delibepidemics/biochemguide/en/index.html
69. World Health Organization. Laboratory biosafety manual. 3rd edition. 2004. Available at: http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf.
70. Laws, war, and public health. [editorial]. Lancet 361 (2003) 1399
71. Holdstock D. Reacting to terrorism: the response should be through law not war. BMJ 323 (2001) 822
72. Fidler D.P. Emerging trends in international law concerning global infectious disease control. Emerg Infect Dis 9 (2003) 285-290
73. Sliverman R. Legal preparedness: the modelization of state, national and international public health law. In: Khardori N. (Ed). Bioterrorism preparedness: medicine-public health-policy (2006), Wiley-VCH, Weinheim